메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 23, Issue 5, 2005, Pages 1044-1045
In reply [2]
Author keywords

[No Author keywords available]
Indexed keywords

ACUTE PHASE PROTEIN; ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; INTERLEUKIN 6;
EID: 33846798310     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.155     Document Type: Letter
Times cited : (1)
References (6)
  • 1
    • 0023887261 scopus 로고
    • Recombinant human interleukin-6 (IL6/BSF-2/HSF) regulates the synthesis of acute-phase proteins in human hepatocytes
    • Castell JV, Gomez-Lechon MJ, David M, et al: Recombinant human interleukin-6 (IL6/BSF-2/HSF) regulates the synthesis of acute-phase proteins in human hepatocytes. FEBS Lett 232:347-350, 1988
    • (1988) FEBS Lett , vol.232 , pp. 347-350
    • Castell, J.V.1    Gomez-Lechon, M.J.2    David, M.3
  • 2
    • 0032814983 scopus 로고    scopus 로고
    • Control of hepatic parameters in renal cell carcinoma (RCC) by interleukin-6 (IL6)
    • Wechsel HW, Feil G, Lahme S, et al: Control of hepatic parameters in renal cell carcinoma (RCC) by interleukin-6 (IL6). Anticancer Res 19:2577-2582, 1999
    • (1999) Anticancer Res , vol.19 , pp. 2577-2582
    • Wechsel, H.W.1    Feil, G.2    Lahme, S.3
  • 3
    • 0025853227 scopus 로고
    • Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: Correlation with disease activity and other prognostic parameters
    • Nachbaur DM, Herold M, Maneschg A, et al: Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: Correlation with disease activity and other prognostic parameters. Ann Hematol 62:54-58, 1991
    • (1991) Ann Hematol , vol.62 , pp. 54-58
    • Nachbaur, D.M.1    Herold, M.2    Maneschg, A.3
  • 4
    • 0031415831 scopus 로고    scopus 로고
    • Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma
    • Ljungberg B, Grankvist K, Rasmuson T: Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma. Eur J Cancer 33:1794-1798, 1997
    • (1997) Eur J Cancer , vol.33 , pp. 1794-1798
    • Ljungberg, B.1    Grankvist, K.2    Rasmuson, T.3
  • 5
    • 0036739439 scopus 로고    scopus 로고
    • Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinoma treated by cytokines: A report from the Groupe Français d'Immunothérapie
    • Negrier S, Escudier B, Gomez F, et al: Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinoma treated by cytokines: A report from the Groupe Français d'Immunothérapie. Ann Oncol 13:1460-1468, 2002
    • (2002) Ann Oncol , vol.13 , pp. 1460-1468
    • Negrier, S.1    Escudier, B.2    Gomez, F.3
  • 6
    • 2942756034 scopus 로고    scopus 로고
    • Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: Prognostic value of interleukin-6-From the Groupe Français d'Immunothérapie
    • Negrier S, Perol D, Menetrier-Caux C, et al: Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: Prognostic value of interleukin-6-From the Groupe Français d'Immunothérapie. J Clin Oncol 22:2371-2378, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 2371-2378
    • Negrier, S.1    Perol, D.2    Menetrier-Caux, C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.